+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04659343

Optimizing Treatment with Drug Monitoring in Adults with Metastatic Renal Cell Carcinoma

Led by Niels Fristrup · Updated on 2026-05-04

200

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand how monitoring the levels of cancer treatment drugs in the blood can help improve outcomes for patients with metastatic renal cell carcinoma mRCC. It focuses on how drug levels relate to treatment effectiveness and side effects, and also studies the role of antibodies and genetic variations in patients receiving checkpoint immunotherapy CPI. The study also explores how the microbiome and certain gene polymorphisms may affect treatment response and survival. Patients with mRCC treated with drugs such as axitinib, cabozantinib, pazopanib, sorafenib, sunitinib, tivozanib, ipilimumab, and nivolumab will be observed. Blood samples will be collected regularly over six months for those on tyrosine kinase inhibitors TKIs, while CPI-treated patients will have blood and stool samples taken from the start of treatment up to two years or until treatment failure. These samples will be analyzed for drug concentrations, antibodies, genetic markers, and microbiome characteristics. Participants will have various assessments including overall survival, progression-free survival, and quality of life measured using the FKSI-19 questionnaire over a 12-month follow-up. Researchers will track drug levels, antibody development, genetic variations, microbiome profiles, and circulating tumor DNA as markers of disease activity and treatment response. This observational study will follow Danish patients over a seven-year period to gather detailed data to better tailor treatments and improve patient care.

CONDITIONS

Brief Title

TDM for Optimized Outcome in Patients With mRCC.

Research Team

N

Niels Fristrup, MD, PhD

J

Jakob N Henriksen, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here